This inventor holds 29 USPTO granted patents and 15 published patent applications, plus 6 CIPO patents and 20 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Vifor (International) Ag, Vifor Fresenius Medical Care Renal Pharma Ltd.. Active years: 2001-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- St. Gallen, CH (2001)
- Wittenbach, CH (2009 - 2017)
- Arbon, CH (2016 - 2023)
Company Filing History:
15 out of 29 
14 out of 15 Years Active: 2001-2023
Areas of Expertise:
Title: Innovator Erik Philipp: A Pioneer in Pharmaceutical Advancements
Introduction
Erik Philipp, a prolific inventor based in Arbon, Switzerland, has made significant strides in the field of pharmaceuticals, with a remarkable portfolio of 29 patents. His innovative contributions focus primarily on iron carbohydrate complexes and phosphate binder particles, which play a vital role in addressing iron deficiency conditions.
Latest Patents
One of Erik Philipp's latest inventions is the development of aqueous iron carbohydrate complexes, which can be produced from an aqueous solution of iron (III) salt and the oxidation product of maltodextrins, using an alkaline hypochlorite solution. This complex is essential for creating medicaments aimed at the treatment and prevention of iron deficiency. Another notable patent involves a pharmaceutical composition that incorporates specific phosphate binder particles with defined particle size distributions, focusing on the formulation and manufacture of these critical components for enhancing health outcomes.
Career Highlights
Throughout his career, Erik Philipp has been associated with prominent organizations, including Vifor International AG and Vifor Fresenius Medical Care Renal Pharma Ltd. His work in these companies has been instrumental in advancing pharmaceutical innovations, particularly in iron supplementation and phosphate regulation.
Collaborations
Erik Philipp’s collaborations with esteemed colleagues such as Peter Geisser and Ludwig Daniel Weibel have further enriched his work in the pharmaceutical industry. Their combined expertise has led to breakthroughs that address significant health challenges associated with iron deficiency and phosphate management.
Conclusion
Erik Philipp’s dedication to innovation in pharmaceuticals reflects his commitment to solving health issues through scientific advancement. With 29 patents to his name, he continues to be a pivotal figure in the development of new medicinal therapies, establishing himself as a leading inventor in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile